Entasis dips in first trading day after $75M IPO

Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX) slipped $4.34 (29%) to $10.66 on Wednesday after it raised $75 million through the sale of 5 million shares at $15 in its IPO.

The offering price valued Entasis at $195.1 million. Entasis priced below its proposed range, but upsized the share offering; it had hoped to sell 4.4 million shares at $16-$18. Underwriters are Credit Suisse, BMO Capital Markets, SunTrust Robinson Humphrey and Wedbush PacGrow...